Protocol for a QUALICOPC study in a Malaysian setting: Primary care pharmacy services system performance and T2DM older adults’ quality of life evaluation
PLOS One · 2025
DOI: 10.1371/journal.pone.0323183 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Nurain Suleiman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health Research, Graduate School of Medicine, Juntendo University, Tokyo, Japan. Hauptthemen laut MEDLINE: Quality of Life, Primary Health Care, Diabetes Mellitus, Type 2, Pharmaceutical Services. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan International Cooperation Agency.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Pharmacists may play a crucial role in enhancing the primary care (PC) system by offering convenient patient care and leveraging their expertise to promote community health through pharmaceutical care and value-added services. Given the significant healthcare issue of Type 2 Diabetes Mellitus (T2DM) in Malaysia and other Asian countries, the associated treatment costs have become a global economic concern. The increasing prevalence of T2DM in Malaysia, particularly among older adults, is intensifying its clinical and economic impact on the country. To address this, the current study aims to evaluate the effectiveness of PC pharmacies using the Quality and Costs of Primary Care (QUALICOPC) Survey, which is widely used in Europe and other developed and developing countries. This research seeks to collect experience and value feedback from older adults with T2DM or their caregivers, and job satisfaction feedback from pharmacy staff. Additionally, the quality of life (QOL) of older adults with T2DM will be assessed among the patients who are respondents in this study. This study will use the adapted and validated QUALICOPC questionnaires that are in line with international standards and tailored to the Malaysian context. An expert panel, including the Pharmaceutical Services Division of the Ministry of Health (MOH) Malaysia and the Kulliyyah of Pharmacy at the International Islamic University Malaysia (IIUM), has been involved in the content validity of the adapted QUALICOPC questionnaires. The QUALICOPC questionnaires will be validated for the construct with a minimum of 38 samples for each client experience questionnaire, 30 samples for each value questionnaire, and 19 samples for the staff questionnaire. The survey will involve 192 samples from each group of T2DM older adults or caregivers and all corresponding public PC pharmacy staff. The QOL will be evaluated using the EuroQol (EQ) 5-dimensions 5-levels [EQ-5D-5L] and an EQ visual analog scale (EQ-VAS). The findings from this study will be valuable for informing the World Health Organization (WHO) and the Malaysian government in designing more effective health policies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Global Health Research, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
- Ministry of Health Malaysia, Training Division, Federal Government Administrative Centre, Putrajaya, Malaysia.
ORCID-Profile: Nurain Suleiman, Ishtiaq Ahmad
Förderung
- Japan International Cooperation Agency
Zitieren
APA
Suleiman, N., Ahmad, I., & Yuasa, M. (2025). Protocol for a QUALICOPC study in a Malaysian setting: Primary care pharmacy services system performance and T2DM older adults’ quality of life evaluation. PLOS One. https://doi.org/10.1371/journal.pone.0323183
Vancouver
Suleiman N, Ahmad I, Yuasa M. Protocol for a QUALICOPC study in a Malaysian setting: Primary care pharmacy services system performance and T2DM older adults’ quality of life evaluation. PLOS One. 2025. doi:10.1371/journal.pone.0323183
BibTeX
@article{Suleiman2025,
author = {Suleiman, Nurain and Ahmad, Ishtiaq and Yuasa, Motoyuki},
title = {Protocol for a QUALICOPC study in a Malaysian setting: Primary care pharmacy services system performance and T2DM older adults’ quality of life evaluation},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0323183}
}
EUVIMED